Veoneer Stock Price, News & Analysis (NYSE:VNE)

Veoneer trades on the New York Stock Exchange (NYSE) under the ticker symbol "VNE."

Veoneer Inc (NYSE:VNE) announced its quarterly earnings results on Friday, July, 26th. The company reported ($1.39) EPS for the quarter, beating analysts' consensus estimates of ($1.57) by $0.18. The company earned $489 million during the quarter, compared to analyst estimates of $482.35 million. Veoneer had a negative return on equity of 23.18% and a negative net margin of 22.11%. View Veoneer's Earnings History.

Veoneer is scheduled to release their next quarterly earnings announcement on Wednesday, October 23rd 2019. View Earnings Estimates for Veoneer.

Veoneer will be holding an earnings conference call on Wednesday, October 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

13 Wall Street analysts have issued 12-month price targets for Veoneer's shares. Their predictions range from $18.00 to $43.00. On average, they expect Veoneer's stock price to reach $29.56 in the next twelve months. This suggests a possible upside of 79.6% from the stock's current price. View Analyst Price Targets for Veoneer.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veoneer in the last year. There are currently 1 sell rating, 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Veoneer.

Headlines about VNE stock have been trending somewhat negative on Thursday, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Veoneer earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Veoneer.

Veoneer saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 8,610,000 shares, a drop of 10.5% from the August 30th total of 9,620,000 shares. Based on an average daily trading volume, of 655,100 shares, the days-to-cover ratio is currently 13.1 days. Approximately 7.8% of the company's shares are sold short. View Veoneer's Current Options Chain.

Some companies that are related to Veoneer include Gentex (GNTX), Allison Transmission (ALSN), Dorman Products (DORM), LCI Industries (LCII), Adient (ADNT), Dana (DAN), Meritor (MTOR), Gentherm (THRM), Delphi Technologies (DLPH), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Stoneridge (SRI), IOCHPE MAXION S/S (IOCJY), Garrett Motion (GTX) and Tenneco (TEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Veoneer investors own include Canadian Zinc (CZN), Bayer (BAYN), Seeing Machines (SEE), Eyegate Pharmaceuticals (EYEG), Netflix (NFLX), NVIDIA (NVDA), PepsiCo (PEP), Autoliv (ALV), The Coca-Cola (KO) and Prudential Financial (PRU).

Veoneer's stock is owned by a variety of of institutional and retail investors. Top institutional investors include DNB Asset Management AS (0.75%) and Gateway Investment Advisers LLC (0.10%). Company insiders that own Veoneer stock include Arthur Blanchford, Jan Carlson, Mathias Hermansson and Mikko S Taipale. View Institutional Ownership Trends for Veoneer.

VNE stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS and Gateway Investment Advisers LLC. View Insider Buying and Selling for Veoneer.

Shares of VNE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VNE stock can currently be purchased for approximately $16.46.

Veoneer has a market capitalization of $1.83 billion and generates $2.23 billion in revenue each year. The company earns $-275,000,000.00 in net income (profit) each year or ($3.17) on an earnings per share basis. Veoneer employs 8,600 workers across the globe.View Additional Information About Veoneer.

The official website for Veoneer is http://www.veoneer.com/.

Veoneer's mailing address is KLARABERGSVIADUKTEN 70 SECTION C6 BOX 13089, STOCKHOLM V7, 10302. The company can be reached via phone at 46-8-527-762-00 or via email at [email protected]